Pancreatic Cancer Research

ResearcherShizuoka Cancer CenterActive in the last 2 years

Atsuyuki Maeda

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2731-7836; OpenAlex author ID A5059829141. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 3 papers

Papers 8

  1. Usefulness of an S-1 dosage formula for predicting adverse events in adjuvant chemotherapy for curatively resected pancreatic cancer: an exploratory analysis o… Co-author DOI 10.1007/s00535-026-02413-5↗
  2. High E2F7 Expression Indicates Pancreatic Cancer Aggressiveness and Downregulation of E2F7 Enhances Sensitivity to S-1. Co-author DOI 10.1245/s10434-025-18912-3↗
  3. ASO Visual Abstract: High E2F7 Expression Indicates Pancreatic Cancer Aggressiveness and Downregulation of E2F7 Enhances Sensitivity to S-1. Co-author DOI 10.1245/s10434-026-19134-x↗
  4. Concordance of human equilibrative nucleoside transporter-1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical out… Co-author DOI 10.1002/cnr2.1507↗
  5. Comparison of end-to-end anastomosis and interposition graft during pancreatoduodenectomy with portal vein reconstruction for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00423-019-01749-2↗
  6. Prognostic impact of splenic artery invasion for pancreatic cancer of the body and tail. Co-author DOI 10.1016/j.ijsu.2016.09.076↗
  7. Serum CA19-9 is a significant predictor among preoperative parameters for early recurrence after resection of pancreatic adenocarcinoma. Last author DOI 10.1007/s11605-012-1859-9↗
  8. Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes. First author DOI 10.1097/mpa.0b013e3182156e1b↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Katsuhiko Uesaka · 6 shared papers, 2011–2026 · strength 0.85
  2. Hirochika Toyama · 4 shared papers, 2022–2026 · strength 0.79
  3. Tomohisa Otsu · 2 shared papers, 2026 · strength 0.45
  4. Mitsuro Kanda · 2 shared papers, 2026 · strength 0.45
  5. Masamichi Hayashi · 2 shared papers, 2026 · strength 0.45
  6. Shinji Mii · 2 shared papers, 2026 · strength 0.45
  7. Ryo Ashida · 2 shared papers, 2026 · strength 0.45
  8. Nobumasa Mizuno · 2 shared papers, 2026 · strength 0.45
  9. Motokazu Sugimoto · 2 shared papers, 2026 · strength 0.45
  10. Junpei Yamaguchi · 2 shared papers, 2026 · strength 0.45
  11. Nobuhiko Nakagawa · 2 shared papers, 2026 · strength 0.45
  12. Yukihiro Yokoyama · 2 shared papers, 2026 · strength 0.45
  13. Keizo Fujita · 2 shared papers, 2026 · strength 0.45
  14. Akira Fukutomi · 2 shared papers, 2022–2026 · strength 0.34
  15. Amane Takahashi · 2 shared papers, 2022–2026 · strength 0.34
  16. Narikazu Boku · 2 shared papers, 2022–2026 · strength 0.34
  17. Yukiyasu Okamura · 2 shared papers, 2022–2026 · strength 0.34
  18. Soichiro Morinaga · 2 shared papers, 2022–2026 · strength 0.34
  19. Kazunaga Ishigaki · 1 shared paper, 2026 · strength 0.23
  20. Atsushi Miyamoto · 1 shared paper, 2026 · strength 0.23
  21. Naoto Gotohda · 1 shared paper, 2026 · strength 0.23
  22. Yousuke Nakai · 1 shared paper, 2026 · strength 0.23
  23. Mitsuhiro Fujishiro · 1 shared paper, 2026 · strength 0.23
  24. Atsushi Enomoto · 1 shared paper, 2026 · strength 0.22
  25. Yuji Kaneoka · 2 shared papers, 2016–2019 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.